GNF-2,
778270-11-4,
GNF 2,
3-(6-((4-(Trifluoromethoxy)phenyl)amino)pyrimidin-4-yl)benzamide,
Bcr-abl Inhibitor,
UNII-6D7Q9Z2W7T,
GNF2,
3-[6-[[4-(Trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide,
6D7Q9Z2W7T,
CHEMBL483847,
3-(6-(4-(trifluoromethoxy)phenylamino)pyrimidin-4-yl)benzamide,
3-(6-{[4-(Trifluoromethoxy)phenyl]amino}pyrimidin-4-Yl)benzamide,
MFCD09265253,
AK162819,
C18H13F3N4O2,
3-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzamide,
(3-(6)-(4-Trifluoromethoxy-phenylamino)-pyrimidin-4-yl)-benzamide,
Benzamide, 3-(6-((4-(trifluoromethoxy)phenyl)amino)-4-pyrimidinyl)-,
Benzamide, 3-[6-[[4-(trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]-,
SMR000463555,
3-[6-[[4-(trifluoromethoxy)phenyl]amino]pyrimidin-4-yl]benzamide,
WEVYNIUIFUYDGI-UHFFFAOYSA-N,
3k5v,
AC1NSKR6,
Bcr-abl inhibitor GNF-2,
AC1Q4ZE7,
MLS000911539,
MLS003105943,
MLS006010254,
SCHEMBL925002,
GTPL5935,
CHEBI:91337,
KS-00000SMX,
AOB2065,
DTXSID40228443,
EX-A100,
QCR-247,
HMS2043N17,
HMS2220E13,
HMS3229A19,
HMS3265C23,
HMS3265C24,
HMS3265D23,
HMS3265D24,
HMS3333I20,
HMS3651P06,
BCP06315,
BDBM50325999,
IN1406,
s2899,
ZINC13130939,
AKOS024458139,
CCG-206737,
SB19395,
GNF-2, >=98% (HPLC), solid,
NCGC00346808-01,
NCGC00346808-12,
AS-16705,
BC600496,
HY-11007,
SC-86703,
AB0095647,
AX8294798,
FT-0701979,
ST24041509,
SW219739-1,
Y0451,
A11439,
S-7782,
[3-(6)-(4-Trifluoromethoxy-phenylamino)-pyrimidin-4-yl]-benzamide],
3-[6-(4-trifluoromethoxy-phenylamino)-pyrimidin-4-yl]-benzamide,
3-[6-(4-trifluoromethoxyphenyl-amino)-pyrimidin-4-yl]-benzamide,
STJ,
nchembio760-comp2,
D05UJT,
cc-647,
ACN-029558,
CID5311510,
CS-0012,
A8603,